US equities |
MU $1,088.00 ▲+0.00% SNDK $1,692.42 ▲+0.00% NVDA $237.47 ▲+0.00% INTC $113.12 ▲+0.00% AMD $645.86 ▲+0.00% SPCX $167.60 ▲+0.00% PLTR $194.12 ▲+0.00% SKHY $178.25 ▲+0.00%
FinancialContent

Latest News about FDA Priority Review

Recent news which mentions FDA Priority Review

Agios' Rare Anemia Drug Application Under FDA Priority Review
Tickers AGIO
Tags AGIO General Health Care
From Benzinga
Liminal BioSciences Stock Is Trading Higher On Sale Of Priority Review Voucher For $105M
Tickers LMNL
Tags Market News Biotech LMNL
From Benzinga
Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review
Tickers DARE
Tags Briefs Long Ideas Benzinga
From Benzinga
Roche's Tecentriq As Adjuvant Treatment Under Priority Review With FDA For Early Lung Cancer
Tickers RHHBF RHHBY RHHVF
Tags RHHVF Market News Biotech
From Benzinga